CARIBOU BIOSCIENCES I

Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

08 4 2022 13:07:17 提供 Nasdaq GlobeNewswire

Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

21 3 2022 16:02:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting

08 3 2022 20:19:17 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

07 3 2022 16:10:57 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference

07 2 2022 16:05:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer

18 1 2022 08:00:02 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference

04 1 2022 16:05:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

17 11 2021 16:05:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results

09 11 2021 16:05:03 提供 Nasdaq GlobeNewswire

Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer

08 11 2021 09:00:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

20 10 2021 16:00:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors

29 9 2021 16:05:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

27 9 2021 16:05:00 提供 Nasdaq GlobeNewswire

Caribou Biosciences Announces Publication of Data Demonstrating High Specificity Genome Editing with its Proprietary chRDNA Technology

02 9 2021 16:05:01 提供 Nasdaq GlobeNewswire

Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference

01 9 2021 08:00:02 提供 Nasdaq GlobeNewswire

Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors

25 8 2021 16:00:00 提供 Nasdaq GlobeNewswire